Alison L. Hill

Johns Hopkins University — United States

Immunology and Microbiology · Life Sciences

37h-index7.1kcitations105works10.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HIV Research and Treatment(35), COVID-19 epidemiological studies(34), HIV/AIDS Research and Interventions(26), HIV/AIDS drug development and treatment(18), SARS-CoV-2 and COVID-19 Research(13)

Publications102 total

Improving policy design and epidemic response using integrated models of economic choice and disease dynamics with behavioral feedback
PLoS Computational Biology·2025· 1 citedOpen Access
Scenario Projections of COVID-19 Burden in the US, 2024-2025
UNC Libraries·2025Open Access
Scenario Projections of COVID-19 Burden in the US, 2024-2025
JAMA Network Open·2025· 3 citedOpen Access
Vaccine failure mode determines population-level impact of vaccination campaigns during epidemics
Journal of The Royal Society Interface·2025· 7 citedOpen Access
SIV Env RhmAbs + N-803 at ART initiation prolongs viral decay without disrupting reservoir establishment in SIV-infected infant macaques
PLoS Pathogens·2025· 2 citedOpen Access
Modeling dynamic disease-behavior feedbacks for improved epidemic prediction and response
2024· 1 citedOpen Access
Evaluation of FluSight influenza forecasting in the 2021–22 and 2022–23 seasons with a new target laboratory-confirmed influenza hospitalizations
UNC Libraries·2024Open Access
Vaccine failure mode determines population-level impact of vaccination campaigns during epidemics
2024· 3 citedOpen Access
Challenges of COVID-19 Case Forecasting in the US, 2020–2021
UNC Libraries·2024Open Access
Evaluation of FluSight influenza forecasting in the 2021–22 and 2022–23 seasons with a new target laboratory-confirmed influenza hospitalizations
Nature Communications·2024· 46 citedOpen Access
Impact of opioid overdoses on US life expectancy and years of life lost, by demographic group and stimulant co-involvement: a mortality data analysis from 2019 to 2022
The Lancet Regional Health - Americas·2024· 34 citedOpen Access
Challenges of COVID-19 Case Forecasting in the US, 2020–2021
PLoS Computational Biology·2024· 28 citedOpen Access
Potential impact of annual vaccination with reformulated COVID-19 vaccines: Lessons from the US COVID-19 scenario modeling hub
PLoS Medicine·2024· 13 citedOpen Access
flepiMoP: The evolution of a flexible infectious disease modeling pipeline during the COVID-19 pandemic
Epidemics·2024· 7 citedOpen Access
Evaluation of FluSight influenza forecasting in the 2021-22 and 2022-23 seasons with a new target laboratory-confirmed influenza hospitalizations
2023· 6 citedOpen Access
Evaluation of the US COVID-19 Scenario Modeling Hub for informing pandemic response under uncertainty
Nature Communications·2023· 55 citedOpen Access
Potential impact of annual vaccination with reformulated COVID-19 vaccines: lessons from the U.S. COVID-19 Scenario Modeling Hub
2023· 4 citedOpen Access
Quantifying individual-level heterogeneity in infectiousness and susceptibility through household studies
Epidemics·2023· 14 citedOpen Access
Impact of opioid overdoses on US life expectancy and years of life lost, by demographic group and stimulant co-involvement: a mortality data analysis from 2019-2022
2023· 9 citedOpen Access
Informing pandemic response in the face of uncertainty. <i>An evaluation of the U.S. COVID-19 Scenario Modeling Hub</i>
2023· 6 citedOpen Access
page 1 of 6Next →

Frequent Co-authors

Daniel I. S. Rosenbloom(12), Martin A. Nowak(12), Robert F. Siliciano(11), Anjalika Nande(9), Shaun Truelove(8), Matteo Chinazzi(8), Alessandro Vespignani(8), Janet D. Siliciano(6), Ben Adlam(6), Claire P. Smith(6), Teresa K. Yamana(6), Sen Pei(6), Jeffrey Shaman(6), Jessica T. Davis(6), Kunpeng Mu(6), Xinyue Xiong(6), Ana Pastore y Piontti(6), Ajitesh Srivastava(6), Aniruddha Adiga(6), Benjamin Hurt(6)